EC Number |
Inhibitors |
Structure |
---|
3.4.24.80 | (2R)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-2-[[(4'-methoxybiphenyl-4-yl)sulfonyl](propan-2-yloxy)amino]butanamide |
- |
|
3.4.24.80 | (2R)-4-(acetylamino)-2-[(biphenyl-4-ylsulfonyl)amino]-N-hydroxybutanamide |
- |
|
3.4.24.80 | 1-cyclopropyl-N-hydroxy-4-[(4-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]phenyl)sulfonyl]piperidine-4-carboxamide |
- |
|
3.4.24.80 | 4-([4-[4-(2-chlorophenyl)piperazin-1-yl]phenyl]sulfonyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide |
- |
|
3.4.24.80 | 4-([4-[4-(2-fluorophenyl)piperazin-1-yl]phenyl]sulfonyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide |
- |
|
3.4.24.80 | 4-([4-[4-(4-chlorophenyl)piperidin-1-yl]phenyl]sulfonyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide |
- |
|
3.4.24.80 | AB815 |
against hinge region of MT1-MMP |
|
3.4.24.80 | Acetohydroxamic acid |
inhibition of Co2+-MT1-MMP |
|
3.4.24.80 | AG3340 |
inhibits MT1-MMP in a sub-nanomolar range |
|
3.4.24.80 | AGN3340 |
- |
|